A Study of BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms

Study Site 18, Atlanta

Study Site 13, Aventura

Study Site 15, Lake Worth

Study Site 16, New Orleans

Study Site 14, Houston

Study Site 12, Mesa

Study Site 17, Las Vegas

Study Site 19, San Diego

Study Site 10, Boston

Study Site 11, Boston

Study Site 50, Red Deer

Study Site 51, Mission

Study Site 54, Guelph

Study Site 52, Scarborough Village

Study Site 53, Toronto

Study Site 37, Blackpool

Study Site 34, Cannock

Study Site 31, Glasgow

Study Site 39, Leeds

Study Site 38, Liverpool

Study Site 30, London

Study Site 36, Manchester

Study Site 33, Poole

Study Site 32, Southport

Study Site 35, Stockton-on-Tees